SG3 Management’s ADMA Biologics ADMA Stock Holding History

SG3 Management’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-74,000	Closed	-$104K	–	918
2021 Q4	$104K	Buy	74,000 +68,100	+1,154%	+$89.5K	0.01%	896
2021 Q3	$7K	Sell	5,900 -54,100	-90%	-$75.8K	﹤0.01%	943
2021 Q2	$96K	Hold	60,000	–	–	0.04%	902
2021 Q1	$106K	Buy	+60,000	New	+$137K	0.03%	1045

Other funds holding ADMA

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.83B AUM 190.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Clearline Capital New York $1.29B AUM 38.13% 1-Year Est. Return

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return